Novel fused protein quells inflammation
From Atlanta, at a meeting of the American Society of Hematology
A new compound made from the fusion of two proteins revs up cells to knock down the inflammation underlying a wide range of health problems.
The synthetic creation is dubbed GIFT-15, short for its two components, interleukin-15 and a compound called GMCSF. In lab dish tests, GIFT-15 induced mouse spleen cells to produce interleukin-10, a potent anti-inflammatory protein, reports Moutih Rafei, an immunologist at the Montréal Centre for Experimental Therapeutics in Cancer.
Science News headlines, in your inbox
Headlines and summaries of the latest Science News articles, delivered to your email inbox every Thursday.
Thank you for signing up!
There was a problem signing you up.
Rafei and his colleagues also tested GIFT-15 in mice with transplanted human tissue. While mice without GIFT-15 rejected the transplants outright, animals treated with the fusion protein tolerated it.
In another experiment, GIFT-15 stopped inflammation in spinal cords of mice with a disease similar to multiple sclerosis (MS). Before treatment with GIFT-15, the animals showed loss of muscle control arising from inflammatory nerve damage. Afterward, they recovered within 6 weeks.
The researchers plan to remove some of a patient’s cells, treat them with GIFT-15 in a lab dish, and multiply the cells. Ideally, these cells could then be returned to the patient as anti-inflammatory therapy for MS, organ transplants, inflammatory bowel disease, and other conditions, Rafei says. Being a person’s own cells, they would avoid immune rejection, he says.